Doctors show 'significant interest' in Boston's Watchman
This article was originally published in Clinica
Executive Summary
It may have only been approved just over a week ago, but clinicians are already showing a strong interest in Boston Scientific’s Watchman, according to an analyst survey. The device is designed to prevent stroke by closing the left-atrial appendage (LAA), a bulge in the wall of the left atrium of the heart where blood clots can form in patients with atrial fibrillation (AF).